GlassScriptPhysician profile
Angela Pham
NPI 1316631963
$2,622.48
in general payments reported to CMS, 2019-2025
21 companies · $2,436 in 2025
The $2,436 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.89 · 2024: $130 · 2025: $2,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,516 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,516.23 |
| Education | $106.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $995.42 | 2025 | Erleada, Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $307.12 | 2024-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $273.40 | 2024-2025 | Keytruda, Keytruda Qlex, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $214.48 | 2025 | |
| Procept Biorobotics Corporation | $126.65 | 2025 | |
| Telix Pharmaceuticals | $111.52 | 2025 | Illuccix |
| Astellas Pharma US INC | $97.65 | 2025 | |
| Novo Nordisk INC | $79.73 | 2023-2024 | Ozempic, Rybelsus |
| Accord Healthcare, INC. | $76.54 | 2025 | |
| Pfizer INC. | $66.54 | 2025 | |
| Dendreon Pharmaceuticals LLC | $54.95 | 2025 | Provenge |
| Urogen Pharma, INC. | $42.41 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.93 | 2025 | |
| Boston Scientific Corporation | $28.29 | 2025 | Accolade Sr |
| Mallinckrodt Hospital Products INC. | $20.44 | 2025 | Acthar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $17.07 | 2024 | Prolaris |
| Tolmar, INC. | $16.11 | 2025 | Jatenzo, Eligard |
| Lilly USA, LLC | $15.73 | 2024 | Mounjaro |
| Progenics Pharmaceuticals, INC. | $15.54 | 2025 | |
| Exact Sciences Corporation | $14.98 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $14.98 | 2025 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.